About ATI Pharma
Executive Team
The leaders driving ATI Pharma's vision of science-led healthcare innovation from research to market.
Our Leadership
Meet the team
ATI Pharma's executive team combines deep scientific expertise with commercial acumen, guiding the company's growth across product development, regulatory affairs, and market expansion.
Together, they lead a multidisciplinary organization committed to bringing innovative, evidence-based healthcare products to patients and consumers across Canada and beyond.
Carmella T. Angus MSc., MBA
CEO and Chairman of the Board
Ms. Angus is a seasoned healthcare executive and entrepreneur with over three decades of experience spanning pharmaceutical commercialization, medical technology, defense R&D, and academic healthcare innovation.
Ms. Angus has founded and led multiple companies, including AC Nova Technologies and Nova DenTech, driving significant P&L growth, executing successful acquisitions, and delivering strong investor returns.
Ms. Angus' career includes co-leading the global launch of Lipitor at Warner-Lambert/Pfizer and recently directing the operational and strategic launch of a contract research organization at the University of Manitoba's Center for Healthcare Innovation.
Holding an MBA in Global Business Management and an MSc in Neuroscience and Cardiovascular Medicine from the University of Toronto, she brings a rare combination of clinical expertise, entrepreneurial leadership, and enterprise-scale execution.